Company Filing History:
Years Active: 2021
Title: Innovations by Stephen F Previs in Diabetes Treatment
Introduction
Stephen F Previs is an accomplished inventor based in Branchburg, NJ (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the use of glucagon receptor antagonists in combination with cholesterol absorption inhibitors.
Latest Patents
Stephen F Previs holds 1 patent for his invention titled "Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor." This patent discloses the use of a glucagon receptor antagonist alongside a cholesterol absorption inhibitor for the treatment of diabetes and related conditions.
Career Highlights
Stephen is currently employed at Merck Sharp & Dohme Corporation, where he continues to advance his research in diabetes treatment. His work has the potential to improve the lives of many individuals suffering from this chronic condition.
Collaborations
Stephen has collaborated with notable colleagues, including Hong-Ping Guan and Jose M Castro-Perez, to further enhance the impact of his research.
Conclusion
Stephen F Previs is a key figure in the innovation of diabetes treatment, with a focus on glucagon receptor antagonists and cholesterol absorption inhibitors. His contributions are paving the way for new therapeutic approaches in managing diabetes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.